Peter Pompei, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
- Since medical school
- 49 years
- University of Chicago, Pritzker School of Medicine, 1977
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pompei’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G78134 · Current
Licensed to practise in California · since 1993 · expires 2027-03-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$8,496
Medicare paid this office $8,496 for 123 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 51 | $2,740 | $54 |
| Return visit (30+ min) | 19 | $1,671 | $88 |
| Short return visit | 34 | $1,128 | $29 |
Who their Medicare patients are
123 Original Medicare patients in 2024. Average age 72 · Women 55% · Also on Medicaid 42% · Health risk score 1.28. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 72% · Diabetes 37% · Coronary heart disease 28% · Depression 23% · Chronic kidney disease 21% · Cancer 18% · Atrial fibrillation 18% · Heart failure 17% · Stroke 12%.
The office billed $24,262, Medicare allowed $11,004 and paid $8,496; for 138 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 123 | 138 | 72 | 1.28 | $24,262 | $8,496 |
| 2023 | 127 | 144 | 71 | 1.51 | $26,082 | $8,507 |
| 2022 | 104 | 108 | 69 | 1.40 | $32,862 | $8,697 |
| 2021 | 77 | 86 | 70 | 1.28 | $22,742 | $4,840 |
| 2020 | 71 | 76 | 66 | 2.05 | $22,331 | $4,109 |
| 2019 | 128 | 145 | 70 | 1.71 | $9,784 | $6,441 |
| 2018 | 168 | 210 | 77 | 1.57 | $16,963 | $9,453 |
| 2017 | 252 | 420 | 76 | 1.59 | $64,039 | $24,913 |
| 2016 | 368 | 900 | 75 | 1.76 | $162,722 | $56,323 |
| 2015 | 416 | 1,094 | 75 | 1.60 | $198,590 | $71,044 |
| 2014 | 476 | 1,343 | 75 | 1.66 | $250,201 | $89,355 |
| 2013 | 455 | 1,350 | 75 | 1.59 | $247,801 | $87,837 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $2,074 | $160 |
| Short return visit (20+ min) | 35 | $1,906 | $53 |
| Return visit (30+ min) | 22 | $1,878 | $82 |
| Short return visit | 55 | $1,765 | $29 |
2022: 4 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $2,232 | $159 |
| Short return visit (20+ min) | 20 | $1,166 | $58 |
| Short return visit | 27 | $875 | $31 |
| New patient visit (15+ min) | 15 | $558 | $37 |
2021: 3 services
| Short return visit | 34 | $1,061 | $30 |
| Short return visit (20+ min) | 19 | $996 | $52 |
| Return visit (30+ min) | 11 | $707 | $64 |
2020: 2 services
| Short return visit (20+ min) | 43 | $1,980 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $889 | $68 |
2019: 2 services
| Short return visit (20+ min) | 108 | $4,921 | $41 |
| Return visit (30+ min) | 15 | $992 | $66 |
2018: 3 services
| Return visit (30+ min) | 74 | $4,314 | $52 |
| Short return visit (20+ min) | 85 | $3,430 | $37 |
| Short return visit (20+ min) | 18 | $783 | $44 |
2017: 3 services
| Return visit (30+ min) | 201 | $17,581 | $64 |
| Short return visit (20+ min) | 55 | $2,465 | $42 |
| New patient visit (45+ min) | 16 | $1,655 | $103 |
2016: 6 services
| Return visit (30+ min) | 282 | $29,577 | $60 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 34 | $14,513 | $59 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 25 | $4,512 | $146 |
| New patient visit (45+ min) | 25 | $2,442 | $98 |
| Short return visit (20+ min) | 40 | $1,800 | $44 |
| Nursing facility discharge day management, 30 minutes or less | 20 | $1,396 | $63 |
2015: 6 services
| Return visit (30+ min) | 314 | $32,496 | $61 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 60 | $23,320 | $60 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 48 | $7,890 | $146 |
| New patient visit (45+ min) | 25 | $2,282 | $91 |
| Nursing facility discharge day management, 30 minutes or less | 29 | $2,062 | $64 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 11 | $612 | $32 |
2014: 6 services
| Return visit (30+ min) | 354 | $39,287 | $61 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 89 | $27,619 | $60 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 77 | $12,739 | $146 |
| Nursing facility discharge day management, 30 minutes or less | 51 | $3,695 | $64 |
| New patient visit (45+ min) | 36 | $2,797 | $78 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 11 | $812 | $35 |
2013: 7 services
| Return visit (30+ min) | 325 | $35,037 | $59 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 84 | $29,005 | $59 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 65 | $10,784 | $142 |
| New patient visit (45+ min) | 53 | $4,844 | $91 |
| Nursing facility discharge day management, 30 minutes or less | 36 | $2,313 | $64 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 20 | $2,088 | $61 |
| Short return visit (20+ min) | 15 | $484 | $30 |
Medicaid work
$105 in 2023
Medicaid paid $105 for 18 billed services this clinician did in 2023, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 18 | $105 |
| 2023 | 18 | 1 | 18 | $105 |
| 2022 | 16 | 1 | 16 | $33 |
| 2021 | 13 | 1 | 13 | $74 |
| 2020 | 28 | 1 | 15 | $398 |
| 2019 | 92 | 1 | 22 | $980 |
| 2018 | 126 | 2 | 20 | $1,606 |
See the largest Medicaid services in earlier years
2022
| Short return visit | 16 | $33 |
2021
| Short return visit | 13 | $74 |
2020
| Short return visit (20+ min) | 28 | $398 |
2019
| Short return visit (20+ min) | 92 | $980 |
2018
| Return visit (30+ min) | 60 | $948 |
| Short return visit (20+ min) | 66 | $658 |
Drugs they prescribed that Part D paid
$10,078
Pharmacies billed $10,078 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 129) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
119 generic and fewer than 11 brand-name prescriptions · $10,078 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 14 | $448 | $32 |
| Fluticasone Propionate | 13 | $124 | $10 |
| Labetalol | 11 | $84 | $8 |
Year by year
| 2024 | 129 | 28 | 0% (0) | None | $10,078 |
| 2023 | 78 | 24 | 0% (0) | 15% | $9,868 |
| 2022 | 42 | None | 0% (0) | 31% | $8,008 |
| 2021 | 91 | 32 | None | 16% | $7,285 |
| 2020 | 251 | 58 | None | 20% | $40,032 |
| 2019 | 699 | 145 | None | 18% | $68,790 |
| 2018 | 2,101 | 230 | 3% (53) | None | $139,164 |
| 2017 | 3,146 | 318 | 3% (87) | 16% | $237,118 |
| 2016 | 4,080 | 364 | 4% (159) | 17% | $291,468 |
| 2015 | 3,963 | 360 | 3% (136) | 19% | $264,355 |
| 2014 | 4,162 | 376 | 3% (138) | 23% | $270,338 |
| 2013 | 4,133 | 385 | 4% (158) | 23% | $236,595 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Atorvastatin | 14 | $522 | $37 |
2022: 1 drug
| Atorvastatin | 11 | $342 | $31 |
2020: 7 drugs
| Spiriva | 13 | $5,865 | $451 |
| Levothyroxine | 12 | $348 | $29 |
| Amlodipine Besylate | 29 | $330 | $11 |
| Omeprazole | 17 | $194 | $11 |
| Atorvastatin | 15 | $148 | $10 |
| Lisinopril | 23 | $144 | $6 |
| Losartan | 13 | $114 | $9 |
2019: 18 drugs
| Creon | 12 | $27,993 | $2,333 |
| Spiriva | 14 | $7,523 | $537 |
| Eliquis | 12 | $7,075 | $590 |
| Ventolin Hfa | 14 | $831 | $59 |
| Atorvastatin | 41 | $671 | $16 |
| Levothyroxine | 24 | $648 | $27 |
| Amlodipine Besylate | 65 | $519 | $8 |
| Hydrocortisone | 13 | $355 | $27 |
| Lisinopril | 38 | $271 | $7 |
| Losartan | 23 | $217 | $9 |
| Omeprazole | 18 | $209 | $12 |
| Metformin | 18 | $163 | $9 |
| Fluoxetine | 12 | $141 | $12 |
| Fluticasone Propionate | 22 | $135 | $6 |
| Famotidine | 17 | $105 | $6 |
| Trazodone | 21 | $68 | $3 |
| Hydrochlorothiazide | 18 | $64 | $4 |
| Lovastatin | 12 | $37 | $3 |
2018: 55 drugs
| Creon | 13 | $28,679 | $2,206 |
| Lyrica | 11 | $8,819 | $802 |
| Silenor | 17 | $7,372 | $434 |
| Lantus | 15 | $5,596 | $373 |
| Spiriva | 13 | $5,189 | $399 |
| Esomeprazole Magnesium | 15 | $3,945 | $263 |
| Dexilant | 11 | $3,063 | $278 |
| Atorvastatin | 127 | $2,256 | $18 |
| Voltaren | 24 | $1,752 | $73 |
| Gabapentin | 64 | $1,465 | $23 |
| Allopurinol | 57 | $1,296 | $23 |
| Amlodipine Besylate | 159 | $1,180 | $7 |
| Metoprolol | 22 | $957 | $43 |
| Tamsulosin | 28 | $924 | $33 |
| Diclofenac | 28 | $912 | $33 |
| Levothyroxine | 34 | $907 | $27 |
| Rosuvastatin | 20 | $850 | $42 |
| Ventolin Hfa | 13 | $799 | $61 |
| Celecoxib | 11 | $775 | $70 |
| Losartan | 73 | $697 | $10 |
| Prazosin | 18 | $655 | $36 |
| Lisinopril | 98 | $653 | $7 |
| Potassium Chloride | 12 | $650 | $54 |
| Ranitidine | 12 | $616 | $51 |
| Finasteride | 22 | $603 | $27 |
| Fluticasone Propionate | 47 | $548 | $12 |
| Fluoxetine | 23 | $536 | $23 |
| Simvastatin | 49 | $513 | $10 |
| Omeprazole | 44 | $457 | $10 |
| Pantoprazole | 24 | $453 | $19 |
| Polyethylene Glycol 3350 | 12 | $449 | $37 |
| Trazodone | 38 | $442 | $12 |
| Labetalol | 12 | $367 | $31 |
| Metformin | 41 | $355 | $9 |
| Hydrocodone-Acetaminophen | 17 | $330 | $19 |
| Famotidine | 19 | $307 | $16 |
| Pravastatin | 21 | $285 | $14 |
| Clopidogrel | 29 | $284 | $10 |
| Triamcinolone Acetonide | 21 | $264 | $13 |
| Tramadol | 18 | $251 | $14 |
| Carvedilol | 30 | $245 | $8 |
| Doxazosin Mesylate | 16 | $242 | $15 |
| Lovastatin | 20 | $238 | $12 |
| Furosemide | 44 | $227 | $5 |
| Atenolol | 32 | $225 | $7 |
| Benazepril | 21 | $193 | $9 |
| Hydrochlorothiazide | 49 | $186 | $4 |
| Metoprolol | 36 | $182 | $5 |
| Warfarin | 12 | $150 | $12 |
| Citalopram Hbr | 29 | $136 | $5 |
| Glipizide | 34 | $99 | $3 |
| Naproxen | 12 | $91 | $8 |
| Donepezil | 13 | $73 | $6 |
| Alendronate | 14 | $71 | $5 |
| Dicyclomine | 11 | $49 | $4 |
2017: 68 drugs
| Tivicay | 13 | $37,758 | $2,904 |
| Lyrica | 27 | $14,331 | $531 |
| Edurant | 13 | $11,890 | $915 |
| Januvia | 17 | $10,188 | $599 |
| Spiriva | 16 | $8,865 | $554 |
| Advair Diskus | 23 | $8,693 | $378 |
| Xarelto | 23 | $7,678 | $334 |
| Silenor | 17 | $6,969 | $410 |
| Lantus | 17 | $4,343 | $255 |
| Ranexa | 13 | $4,264 | $328 |
| Atorvastatin | 146 | $2,314 | $16 |
| Duloxetine | 11 | $2,174 | $198 |
| Gabapentin | 82 | $2,092 | $26 |
| Lidocaine | 17 | $2,081 | $122 |
| Tamsulosin | 60 | $2,011 | $34 |
| Levothyroxine | 75 | $1,866 | $25 |
| Potassium Chloride | 35 | $1,495 | $43 |
| Metoprolol | 46 | $1,431 | $31 |
| Allopurinol | 62 | $1,302 | $21 |
| Valsartan | 22 | $1,137 | $52 |
| Amlodipine Besylate | 131 | $1,076 | $8 |
| Rosuvastatin | 11 | $989 | $90 |
| Promethazine | 15 | $987 | $66 |
| Lisinopril | 153 | $951 | $6 |
| Fluticasone Propionate | 59 | $915 | $16 |
| Simvastatin | 80 | $901 | $11 |
| Omeprazole | 108 | $890 | $8 |
| Polyethylene Glycol 3350 | 31 | $859 | $28 |
| Ranitidine | 40 | $851 | $21 |
| Fluoxetine | 34 | $810 | $24 |
| Mirtazapine | 15 | $717 | $48 |
| Metformin | 72 | $709 | $10 |
| Finasteride | 23 | $650 | $28 |
| Enalapril Maleate | 12 | $634 | $53 |
| Losartan | 72 | $632 | $9 |
| Trazodone | 35 | $613 | $18 |
| Pantoprazole | 45 | $613 | $14 |
| Pravastatin | 26 | $561 | $22 |
| Lovastatin | 32 | $557 | $17 |
| Hydrocodone-Acetaminophen | 31 | $527 | $17 |
| Labetalol | 15 | $514 | $34 |
| Nyamyc | 22 | $451 | $20 |
| Doxazosin Mesylate | 18 | $450 | $25 |
| Citalopram Hbr | 54 | $441 | $8 |
| Tramadol | 38 | $425 | $11 |
| Oxybutynin Chloride | 19 | $416 | $22 |
| Quetiapine | 34 | $415 | $12 |
| Ipratropium | 16 | $412 | $26 |
| Baclofen | 14 | $378 | $27 |
| Hydrochlorothiazide | 94 | $361 | $4 |
| Valsartan-Hydrochlorothiazide | 18 | $314 | $17 |
| Digoxin | 14 | $308 | $22 |
| Furosemide | 63 | $305 | $5 |
| Verapamil | 13 | $271 | $21 |
| Prednisone | 23 | $270 | $12 |
| Glipizide | 36 | $227 | $6 |
| Alendronate | 38 | $213 | $6 |
| Metoprolol | 41 | $210 | $5 |
| Atenolol | 41 | $209 | $5 |
| Famotidine | 16 | $191 | $12 |
| Paroxetine | 12 | $187 | $16 |
| Benazepril | 19 | $179 | $9 |
| Clopidogrel | 20 | $177 | $9 |
| Carvedilol | 28 | $174 | $6 |
| Sertraline | 17 | $167 | $10 |
| Triamcinolone Acetonide | 22 | $154 | $7 |
| Diltiazem | 13 | $153 | $12 |
| Lorazepam | 13 | $65 | $5 |
2016: 82 drugs
| Nexium | 25 | $20,132 | $805 |
| Lidocaine | 36 | $19,238 | $534 |
| Januvia | 24 | $11,272 | $470 |
| Crestor | 16 | $9,822 | $614 |
| Spiriva | 19 | $9,531 | $502 |
| Advair Diskus | 13 | $7,919 | $609 |
| Pradaxa | 22 | $7,776 | $353 |
| Exelon | 26 | $6,715 | $258 |
| Silenor | 17 | $6,376 | $375 |
| Lyrica | 14 | $6,256 | $447 |
| Fentanyl | 12 | $5,983 | $499 |
| Lantus | 23 | $5,835 | $254 |
| Xarelto | 18 | $4,202 | $233 |
| Clobetasol Propionate | 11 | $3,866 | $351 |
| Omega-3 Acid Ethyl Esters | 13 | $3,718 | $286 |
| Metoprolol | 75 | $3,418 | $46 |
| Tamsulosin | 81 | $3,231 | $40 |
| Gabapentin | 127 | $2,953 | $23 |
| Atorvastatin | 142 | $2,675 | $19 |
| Niacin Er | 13 | $2,019 | $155 |
| Valsartan | 29 | $1,811 | $62 |
| Levothyroxine | 71 | $1,750 | $25 |
| Celecoxib | 24 | $1,714 | $71 |
| Hydrocodone-Acetaminophen | 55 | $1,661 | $30 |
| Quetiapine | 40 | $1,377 | $34 |
| Omeprazole | 117 | $1,351 | $12 |
| Polyethylene Glycol 3350 | 40 | $1,293 | $32 |
| Voltaren | 24 | $1,238 | $52 |
| Lisinopril | 179 | $1,201 | $7 |
| Metformin | 116 | $1,144 | $10 |
| Oxycodone-Acetaminophen | 14 | $1,121 | $80 |
| Nyamyc | 30 | $1,097 | $37 |
| Potassium Chloride | 23 | $1,072 | $47 |
| Amlodipine Besylate | 176 | $1,068 | $6 |
| Duloxetine | 12 | $1,012 | $84 |
| Losartan | 94 | $1,008 | $11 |
| Memantine | 27 | $996 | $37 |
| Allopurinol | 49 | $932 | $19 |
| Simvastatin | 90 | $893 | $10 |
| Dutasteride | 13 | $863 | $66 |
| Pantoprazole | 41 | $822 | $20 |
| Synthroid | 21 | $793 | $38 |
| Mirtazapine | 12 | $790 | $66 |
| Baclofen | 33 | $724 | $22 |
| Finasteride | 28 | $716 | $26 |
| Enalapril Maleate | 18 | $709 | $39 |
| Fluticasone Propionate | 59 | $708 | $12 |
| Divalproex | 21 | $696 | $33 |
| Ranitidine | 48 | $673 | $14 |
| Hydrochlorothiazide | 127 | $635 | $5 |
| Clopidogrel | 36 | $615 | $17 |
| Fluoxetine | 47 | $609 | $13 |
| Citalopram Hbr | 75 | $601 | $8 |
| Hydralazine | 14 | $589 | $42 |
| Pravastatin | 22 | $571 | $26 |
| Trazodone | 46 | $554 | $12 |
| Famotidine | 34 | $537 | $16 |
| Oxybutynin Chloride | 21 | $513 | $24 |
| Donepezil | 22 | $495 | $22 |
| Labetalol | 12 | $482 | $40 |
| Alendronate | 55 | $456 | $8 |
| Metoprolol | 59 | $441 | $7 |
| Zolpidem | 24 | $439 | $18 |
| Furosemide | 61 | $437 | $7 |
| Digoxin | 11 | $401 | $36 |
| Verapamil | 19 | $400 | $21 |
| Tramadol | 41 | $377 | $9 |
| Sertraline | 30 | $355 | $12 |
| Triamcinolone Acetonide | 33 | $324 | $10 |
| Atenolol | 51 | $281 | $6 |
| Lovastatin | 29 | $255 | $9 |
| Warfarin | 19 | $253 | $13 |
| Ondansetron | 11 | $216 | $20 |
| Carvedilol | 28 | $206 | $7 |
| Lorazepam | 28 | $178 | $6 |
| Benazepril | 33 | $172 | $5 |
| Prednisone | 16 | $159 | $10 |
| Glipizide | 34 | $154 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $146 | $12 |
| Ibuprofen | 25 | $144 | $6 |
| Methimazole | 16 | $114 | $7 |
| Dicyclomine | 13 | $32 | $2 |
2015: 83 drugs
| Nexium | 39 | $22,789 | $584 |
| Spiriva | 30 | $14,166 | $472 |
| Crestor | 31 | $13,902 | $448 |
| Januvia | 18 | $13,743 | $763 |
| Atrovent Hfa | 29 | $11,465 | $395 |
| Advair Diskus | 21 | $9,323 | $444 |
| Pradaxa | 26 | $8,750 | $337 |
| Lantus | 18 | $5,720 | $318 |
| Lidocaine | 28 | $5,601 | $200 |
| Fentanyl | 25 | $4,360 | $174 |
| Namenda Xr | 26 | $4,180 | $161 |
| Silenor | 13 | $4,168 | $321 |
| Omega-3 Acid Ethyl Esters | 12 | $3,664 | $305 |
| Econazole Nitrate | 15 | $3,453 | $230 |
| Metoprolol | 74 | $3,409 | $46 |
| Tamsulosin | 68 | $3,279 | $48 |
| Gabapentin | 127 | $3,202 | $25 |
| Premarin | 12 | $2,966 | $247 |
| Diovan | 14 | $2,821 | $201 |
| Atorvastatin | 128 | $2,092 | $16 |
| Levothyroxine | 82 | $2,088 | $25 |
| Valsartan | 17 | $2,034 | $120 |
| Omeprazole | 127 | $2,022 | $16 |
| Voltaren | 35 | $1,731 | $49 |
| Losartan | 96 | $1,501 | $16 |
| Metformin | 138 | $1,437 | $10 |
| Amlodipine Besylate | 197 | $1,385 | $7 |
| Proair Hfa | 21 | $1,355 | $65 |
| Simvastatin | 104 | $1,248 | $12 |
| Quetiapine | 35 | $1,141 | $33 |
| Hydrocodone-Acetaminophen | 38 | $1,038 | $27 |
| Polyethylene Glycol 3350 | 26 | $1,017 | $39 |
| Citalopram Hbr | 91 | $978 | $11 |
| Finasteride | 44 | $970 | $22 |
| Namenda | 11 | $963 | $88 |
| Potassium Chloride | 25 | $953 | $38 |
| Lisinopril | 124 | $929 | $7 |
| Pravastatin | 29 | $912 | $31 |
| Pantoprazole | 49 | $796 | $16 |
| Mirtazapine | 23 | $770 | $33 |
| Enalapril Maleate | 22 | $770 | $35 |
| Alendronate | 85 | $747 | $9 |
| Oxycodone-Acetaminophen | 18 | $746 | $41 |
| Zolpidem | 53 | $653 | $12 |
| Montelukast | 11 | $628 | $57 |
| Fluoxetine | 36 | $601 | $17 |
| Hydrochlorothiazide | 86 | $585 | $7 |
| Fluticasone Propionate | 36 | $543 | $15 |
| Labetalol | 11 | $543 | $49 |
| Allopurinol | 38 | $509 | $13 |
| Hydralazine | 12 | $474 | $40 |
| Oxybutynin Chloride | 16 | $473 | $30 |
| Furosemide | 78 | $436 | $6 |
| Nyamyc | 12 | $426 | $36 |
| Lovastatin | 39 | $413 | $11 |
| Famotidine | 28 | $410 | $15 |
| Donepezil | 26 | $408 | $16 |
| Warfarin | 23 | $350 | $15 |
| Atenolol | 41 | $334 | $8 |
| Verapamil Sr | 17 | $326 | $19 |
| Sertraline | 32 | $312 | $10 |
| Isosorbide Mononitrate Er | 14 | $311 | $22 |
| Clopidogrel | 22 | $307 | $14 |
| Metoprolol | 39 | $288 | $7 |
| Verapamil | 12 | $285 | $24 |
| Carvedilol | 33 | $263 | $8 |
| Benazepril | 31 | $263 | $8 |
| Trazodone | 36 | $260 | $7 |
| Doxazosin Mesylate | 12 | $247 | $21 |
| Triamcinolone Acetonide | 25 | $245 | $10 |
| Glipizide | 59 | $243 | $4 |
| Triamterene-Hydrochlorothiazid | 15 | $242 | $16 |
| Ranitidine | 22 | $230 | $10 |
| Oxycodone | 11 | $221 | $20 |
| Ondansetron | 14 | $205 | $15 |
| Tramadol | 15 | $194 | $13 |
| Synthroid | 13 | $193 | $15 |
| Lorazepam | 37 | $181 | $5 |
| Naproxen | 18 | $180 | $10 |
| Buspirone | 16 | $169 | $11 |
| Propranolol | 12 | $158 | $13 |
| Baclofen | 11 | $125 | $11 |
| Alprazolam | 11 | $67 | $6 |
2014: 95 drugs
| Diovan | 94 | $21,760 | $231 |
| Pradaxa | 35 | $13,109 | $375 |
| Januvia | 14 | $11,940 | $853 |
| Nexium | 21 | $11,435 | $545 |
| Spiriva | 30 | $9,775 | $326 |
| Advair Diskus | 31 | $9,575 | $309 |
| Atrovent Hfa | 27 | $7,128 | $264 |
| Crestor | 20 | $7,049 | $352 |
| Niacin Er | 11 | $5,754 | $523 |
| Metoprolol | 79 | $3,879 | $49 |
| Lidoderm | 14 | $3,879 | $277 |
| Duloxetine | 18 | $3,751 | $208 |
| Lantus | 13 | $3,229 | $248 |
| Gabapentin | 98 | $3,158 | $32 |
| Alphagan P | 14 | $3,019 | $216 |
| Quetiapine | 41 | $3,010 | $73 |
| Valsartan | 11 | $2,682 | $244 |
| Namenda Xr | 15 | $2,578 | $172 |
| Omeprazole | 130 | $2,529 | $19 |
| Atorvastatin | 126 | $2,462 | $20 |
| Azopt | 14 | $2,300 | $164 |
| Levothyroxine | 113 | $2,290 | $20 |
| Nasonex | 12 | $2,075 | $173 |
| Coreg Cr | 12 | $2,061 | $172 |
| Avodart | 14 | $2,005 | $143 |
| Metformin | 141 | $1,971 | $14 |
| Proair Hfa | 37 | $1,917 | $52 |
| Lidocaine | 17 | $1,854 | $109 |
| Amlodipine Besylate | 212 | $1,815 | $9 |
| Polyethylene Glycol 3350 | 46 | $1,750 | $38 |
| Losartan | 85 | $1,689 | $20 |
| Tamsulosin | 54 | $1,566 | $29 |
| Potassium Chloride | 29 | $1,565 | $54 |
| Simvastatin | 129 | $1,399 | $11 |
| Risperidone | 11 | $1,312 | $119 |
| Donepezil | 42 | $1,294 | $31 |
| Humulin R | 12 | $1,238 | $103 |
| Pravastatin | 29 | $1,149 | $40 |
| Nystatin | 26 | $1,147 | $44 |
| Hydrocodone-Acetaminophen | 37 | $1,115 | $30 |
| Lisinopril | 107 | $1,057 | $10 |
| Finasteride | 39 | $992 | $25 |
| Citalopram Hbr | 74 | $925 | $12 |
| Alendronate | 83 | $904 | $11 |
| Clopidogrel | 16 | $891 | $56 |
| Carbamazepine | 12 | $866 | $72 |
| Fluticasone Propionate | 39 | $803 | $21 |
| Oxybutynin Chloride | 12 | $712 | $59 |
| Hydrochlorothiazide | 105 | $680 | $6 |
| Digox | 13 | $619 | $48 |
| Mirtazapine | 35 | $617 | $18 |
| Digoxin | 26 | $577 | $22 |
| Pantoprazole | 27 | $561 | $21 |
| Enalapril Maleate | 27 | $531 | $20 |
| Furosemide | 99 | $526 | $5 |
| Ranitidine | 28 | $509 | $18 |
| Synthroid | 18 | $504 | $28 |
| Oxycodone | 18 | $484 | $27 |
| Klor-Con M20 | 14 | $465 | $33 |
| Benazepril | 26 | $454 | $17 |
| Triamterene-Hydrochlorothiazid | 24 | $452 | $19 |
| Carvedilol | 36 | $440 | $12 |
| Metoprolol | 75 | $427 | $6 |
| Methadone | 17 | $421 | $25 |
| Isosorbide Mononitrate Er | 24 | $402 | $17 |
| Atenolol | 47 | $389 | $8 |
| Allopurinol | 37 | $388 | $10 |
| Chlorthalidone | 12 | $382 | $32 |
| Ondansetron | 25 | $349 | $14 |
| Fluoxetine | 15 | $345 | $23 |
| Haloperidol | 12 | $320 | $27 |
| Zolpidem | 32 | $309 | $10 |
| Fluocinonide | 11 | $307 | $28 |
| Glipizide | 36 | $305 | $8 |
| Lovastatin | 24 | $301 | $13 |
| Paroxetine | 21 | $271 | $13 |
| Hydrocortisone | 32 | $253 | $8 |
| Hydralazine | 14 | $248 | $18 |
| Warfarin | 24 | $241 | $10 |
| Spironolactone | 12 | $222 | $18 |
| Naproxen | 11 | $220 | $20 |
| Buspirone | 11 | $219 | $20 |
| Tizanidine | 16 | $211 | $13 |
| Trazodone | 40 | $197 | $5 |
| Timolol Maleate | 14 | $197 | $14 |
| Tramadol | 24 | $180 | $7 |
| Triamcinolone Acetonide | 16 | $163 | $10 |
| Nitrostat | 11 | $155 | $14 |
| Ciprofloxacin | 11 | $139 | $13 |
| Propranolol | 15 | $116 | $8 |
| Lorazepam | 20 | $99 | $5 |
| Cyclobenzaprine | 17 | $96 | $6 |
| Meloxicam | 12 | $90 | $7 |
| Alprazolam | 13 | $82 | $6 |
| Diazepam | 15 | $68 | $5 |
2013: 98 drugs
| Diovan | 82 | $14,089 | $172 |
| Januvia | 15 | $9,327 | $622 |
| Nexium | 15 | $9,079 | $605 |
| Advair Diskus | 27 | $7,575 | $281 |
| Spiriva | 23 | $6,521 | $284 |
| Cymbalta | 34 | $6,413 | $189 |
| Oxycontin | 15 | $5,806 | $387 |
| Pradaxa | 17 | $5,783 | $340 |
| Atrovent Hfa | 25 | $5,565 | $223 |
| Crestor | 14 | $5,326 | $380 |
| Sensipar | 22 | $5,268 | $239 |
| Celebrex | 14 | $4,825 | $345 |
| Quetiapine | 48 | $4,356 | $91 |
| Lidoderm | 14 | $3,968 | $283 |
| Evista | 15 | $3,712 | $247 |
| Metoprolol | 65 | $3,632 | $56 |
| Atorvastatin | 105 | $3,200 | $30 |
| Omeprazole | 125 | $3,184 | $25 |
| Lovaza | 12 | $2,986 | $249 |
| Nystatin | 47 | $2,581 | $55 |
| Gabapentin | 69 | $2,544 | $37 |
| Losartan | 89 | $2,207 | $25 |
| Amlodipine Besylate | 179 | $1,953 | $11 |
| Simvastatin | 160 | $1,951 | $12 |
| Avodart | 11 | $1,933 | $176 |
| Metformin | 135 | $1,927 | $14 |
| Tamsulosin | 59 | $1,819 | $31 |
| Coreg Cr | 12 | $1,815 | $151 |
| Zetia | 11 | $1,792 | $163 |
| Nasonex | 11 | $1,782 | $162 |
| Fluticasone Propionate | 58 | $1,514 | $26 |
| Polyethylene Glycol 3350 | 44 | $1,464 | $33 |
| Levothyroxine | 109 | $1,408 | $13 |
| Clopidogrel | 16 | $1,298 | $81 |
| Xopenex Hfa | 18 | $1,279 | $71 |
| Finasteride | 27 | $1,229 | $46 |
| Donepezil | 45 | $1,164 | $26 |
| Hydrochlorothiazide | 137 | $1,075 | $8 |
| Proair Hfa | 22 | $1,036 | $47 |
| Humulin R | 12 | $1,015 | $85 |
| Pioglitazone | 11 | $998 | $91 |
| Lisinopril | 111 | $989 | $9 |
| Potassium Chloride | 34 | $862 | $25 |
| Hydrocodone-Acetaminophen | 55 | $791 | $14 |
| Azelastine | 12 | $762 | $64 |
| Alendronate | 54 | $729 | $14 |
| Pantoprazole | 34 | $709 | $21 |
| Diltiazem 24hr Cd | 18 | $701 | $39 |
| Pravastatin | 37 | $680 | $18 |
| Benazepril | 47 | $677 | $14 |
| Metoprolol | 80 | $640 | $8 |
| Synthroid | 21 | $596 | $28 |
| Mirtazapine | 27 | $593 | $22 |
| Atenolol | 71 | $560 | $8 |
| Labetalol | 22 | $542 | $25 |
| Risperidone | 11 | $531 | $48 |
| Carvedilol | 38 | $524 | $14 |
| Warfarin | 56 | $516 | $9 |
| Citalopram Hbr | 45 | $488 | $11 |
| Furosemide | 93 | $471 | $5 |
| Klor-Con M20 | 13 | $418 | $32 |
| Methadone | 23 | $398 | $17 |
| Triamterene-Hydrochlorothiazid | 19 | $391 | $21 |
| Oxybutynin Chloride | 17 | $381 | $22 |
| Spironolactone | 27 | $334 | $12 |
| Irbesartan | 14 | $331 | $24 |
| Glyburide | 11 | $318 | $29 |
| Glipizide | 26 | $314 | $12 |
| Zolpidem | 51 | $305 | $6 |
| Lovastatin | 16 | $301 | $19 |
| Nitrostat | 20 | $289 | $14 |
| Triamterene-Hctz | 25 | $287 | $11 |
| Fluoxetine | 21 | $261 | $12 |
| Ranitidine | 33 | $261 | $8 |
| Acetaminophen-Codeine | 12 | $259 | $22 |
| Enalapril Maleate | 17 | $248 | $15 |
| Isosorbide Mononitrate Er | 14 | $224 | $16 |
| Doxazosin Mesylate | 16 | $223 | $14 |
| Carisoprodol | 18 | $219 | $12 |
| Ipratropium | 12 | $218 | $18 |
| Gemfibrozil | 12 | $193 | $16 |
| Haloperidol | 14 | $183 | $13 |
| Digoxin | 24 | $183 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $181 | $16 |
| Hydrocortisone | 13 | $177 | $14 |
| Chlorthalidone | 11 | $176 | $16 |
| Timolol Maleate | 14 | $168 | $12 |
| Allopurinol | 18 | $165 | $9 |
| Tramadol | 16 | $156 | $10 |
| Trazodone | 27 | $140 | $5 |
| Proctozone-Hc | 14 | $139 | $10 |
| Digox | 16 | $139 | $9 |
| Propranolol | 17 | $135 | $8 |
| Cyclobenzaprine | 17 | $133 | $8 |
| Triamcinolone Acetonide | 15 | $117 | $8 |
| Lorazepam | 20 | $112 | $6 |
| Ibuprofen | 16 | $66 | $4 |
| Diazepam | 11 | $50 | $5 |
Money from drug and device companies
$23 in 2025
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $23 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-04-14 | Wegovy | $23 |
Professional record
- NPI
- 1063554012
- Licence
- CA G78134California G78134: Current · expires 2027-03-31
- Trained
- University of Chicago, Pritzker School of Medicine, 1977 · 49 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G781340
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RG0300X (207RG0300X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-02-13
- NPI last updated
- 2024-04-23
- NPI record certified
- 2024-04-23
This is when the NPI record was last certified, not a medical board exam.